News Daily News Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review Michael O'Riordan December 11, 2025
News Daily News Risk Calculators Miss Many Patients Who Present With First MI Michael O'Riordan November 21, 2025
News Conference News AHA 2025 Lower Mortality With Complete Revascularization in Acute MI Patients With MVD Michael O'Riordan November 12, 2025
News Conference News TCT 2025 iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI Yael L. Maxwell October 28, 2025
News Conference News TCT 2025 STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus Michael O'Riordan October 28, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Opinion CV Team Dispatch September 2025 Dispatch for the CV Team L.A. McKeown September 30, 2025
News Conference News ESC 2025 No Benefit to Routine CT Angiography After Left Main PCI: PULSE Michael O'Riordan August 31, 2025
News Opinion Editor's Corner TCTMD's Top 10 Most Popular Stories for August 2025 Caitlin E. Cox August 28, 2025
News Opinion Editor's Corner ESC 2025 What’s Going to Be Hot at ESC Congress 2025? Michael O'Riordan August 25, 2025
News Daily News Rise in CV Risk Factors Tied to Vulnerable Plaque in ACS Patients Caitlin E. Cox July 14, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2025 Michael O'Riordan June 30, 2025
News Conference News EuroPCR 2025 OCT-Guided PCI Bests Angiography in ACS Patients: OCCUPI L.A. McKeown May 28, 2025
News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025
News Daily News Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA Michael O'Riordan February 24, 2025
News Conference News TCT 2024 QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe Caitlin E. Cox October 30, 2024
News Conference News TCT 2024 Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT Michael O'Riordan October 27, 2024